Pfizer and BioNTech Provide Update on Booster Program in Light of the Delta-Variant

Angie SzumlinskiAnnouncements

Pfizer and BioNTech have seen encouraging data in the ongoing booster trial of a third dose of the current BNT162b2 vaccine. Initial data from the study demonstrate that a booster dose given 6 months after the second dose has a consistent tolerability profile while eliciting high neutralization titers against the wild type and the Beta variant, which are 5 to …

Longer Refrigerator Storage – Pfizer-BioNTech Vaccine – FDA

Angie SzumlinskiFeatured

The following brief was issued by the FDA on May, 19, 2021: Making COVID-19 vaccines widely available is key to getting people vaccinated and bringing the pandemic to an end. Pfizer Inc. submitted data to the FDA to support storage of undiluted, thawed vials of its COVID-19 vaccine for up to one month at refrigerator temperatures. This change should make …

Booster Shot?

Angie SzumlinskiAnnouncements, News

Pfizer has announced it is trialing a third COVID-19 shot to be administered six to 12 months after a patient’s two-dose regimen. The trial will examine whether a booster shot of the Pfizer-BioNTech COVID-19 vaccine would tackle any new strains that emerge, the two companies said. The study will use participants from its Phase I trial in the US “in …